RealMoney.com's DAILY BULLETIN

November 21, 2001

http://www.realmoney.com

************************ADVERTISEMENT*************************

Privista

***Have you seen your credit report lately?***
Don't let fraud or errors ruin your credit rating.  Sign up for Credit
Insight, brought to you by TheStreet.com and get unlimited access to
your credit report.  You'll also receive a credit rating of where you
stand and a record of who's looking at your file!  Click here to sign
up for your FREE credit report today!

http://ad.2clk.net/eclk;3606913;1729382257000484863;6593942;202527;;53948


**************************************************************

o Companies in Today's Bulletin:

Amgen (AMGN:Nasdaq)
Nokia (NOK:NYSE)
Northfield Laboratories (NFLD:Nasdaq)
____________________________________
Reality Test: Ben, at His Most Panglossian, Can't Make Sense of the
Bulls

If the next decade witnesses an unprecedented surge in profit, the
markets still end up near bubble levels.

http://www.thestreet.com/p/rmoney/bensteinfree/10004265.html
____________________________________
Steven Hendlin: Shrink Rap: Market Misery Loves Company

Are you feeling whupped by this market? Join the crowd -- and stop
beating yourself up!

http://www.thestreet.com/comment/shrinkrap/10004253.html
____________________________________
The Real Deal: Home Front: The Motivational Speaker's Job Gets Heavier

Kevin Elko isn't just giving pep talks -- he's talking to brokers about
their postattack emotions.

http://www.thestreet.com/comment/realdeal/10004246.html
____________________________________
Meet the Street: Not Out of the Woods Yet

Lipper analyst Andrew Clark dissects the recent market rally.

http://www.thestreet.com/funds/meetthestreet/10004273.html
____________________________________
Biotech Sage: Some Biotech Mutual Funds Worth Considering

Nadine Wong is the editor, publisher and co-founder of the monthly
BioTech Sage Report. Wong writes a weekly column that appears on this
page as part of her business relationship with TheStreet.com.

http://www.thestreet.com/funds/biotechsagepf/10004264.html
_____________________________________
Biotech/Pharmaceuticals: Amgen Says Pipeline Primed for Next Year

The big biotech company says sales of new products will push earnings
20% higher next year.

http://www.thestreet.com/stocks/biotech/10004270.html
____________________________________
The Night Watch: Amgen Jumps on Strength of Forecast

Analog Devices falls after guiding Wall Street lower.

http://www.thestreet.com/markets/nightwatch/10004269.html
____________________________________
James J. Cramer: Bet on Big Buybacks by Banking Behemoths

In tough times, stock repurchases can represent banks' best use of
capital.

http://www.thestreet.com/p/rmoney/jamesjcramer/10004267.html
____________________________________
Wireless Wiz: Nokia's Great Leap Forward

The phonemaker unveils a radical design with multimedia messaging, but
the rollout could be too slow.

http://www.thestreet.com/comment/wirelesswiz/10004250.html
____________________________________
James J. Cramer: Drillers' Estimates Will Run Dry

Looking for a new short? Try the oil stocks. JJC sees number cuts
imminent here.

http://www.thestreet.com/p/rmoney/jamesjcramer/10004262.html
____________________________________
Detox: Little Pink Elephants for You and Me

The market thinks the economy is recovering, but really we're all just
drunk on easy money.

http://www.thestreet.com/markets/detox/10004257.html
____________________________________
Adam Feuerstein: FDA Sends Northfield Back for a Redesign

It could be a long and expensive road back to drug regulators for the
company's blood substitute.

http://www.thestreet.com/tech/adamfeuerstein/10004266.html
____________________________________
Futures Shock: Talking About a Revolution

With advantages that single-stock futures offer, you have to wonder why
no one thought of them before.

http://www.thestreet.com/comment/futures/10004238.html
______________________________________________________________________
November 21

James J. Cramer will host TheStreet.com's radio show "RealMoney with
Jim Cramer." The show airs daily from 3-4 p.m. EDT. Got a question for
Jim Cramer? Call 1-800-862-8686.
______________________________________________________________________
If you would like to be removed from our bulletin mailing list, or
would like to select which of our bulletins you receive, please go to
the following URL:

http://www.thestreet.com/p/upc/bulletin.jhtml

Copyright Notice

Except for making one printed copy of this or any other materials,
files or documents available from, accessible through or published by
TheStreet.com Inc. for your personal use (or downloading for the same
limited purpose), these may not be reproduced, republished, broadcast
or otherwise distributed without prior written permission of
TheStreet.com Inc.

For bulk reprints of any article, please contact Brad Glouner at
Reprint Management Services, at (717) 399-1900 ext. 130, or via email
at bglouner@rmsreprints.com.
____________________________________________________________________
For general comments, questions or suggestions, please send an email to
feedback@realmoney.com.

For letters about our editorial content intended for publication,
please send an email to letters@realmoney.com. Remember to include your
full name and city.

If you have a question regarding your account, please contact us at
members@realmoney.com.
____________________________________________________________________

For TheStreet.com's privacy policy, please click here:
http://www.thestreet.com/tsc/about/privacy.html.

Email delivery and ad services are provided by DoubleClick's DARTmail.
Click here for important privacy information:
http://www.privacychoices.org/
____________________________________________________________________

Copyright 2000 TheStreet.com, Inc. All rights reserved.